| |
Before N = 123
|
After N = 123
|
Follow-up N = 62
|
Controls N = 65
|
Before vs.
|
Before vs.
|
Before vs.
|
|---|
| |
median (IQR)
|
median (IQR)
|
median (IQR)
|
median (IQR)
|
After
|
Follow-up
|
Controls
|
|---|
|
Abdominal pain
|
92 (79–97)
|
86 (68–96)
|
84 (71–97)
|
93 (73–98)
|
0.052
|
0.041
|
0.881
|
|
Diarrhea
|
94 (82–97)
|
93 (80–96)
|
95 (78–98)
|
95 (80–98)
|
0.617
|
0.778
|
0.812
|
|
Constipation
|
93 (79–97)
|
86 (67–96)
|
93 (73–97)
|
95 (83–98)
|
0.004
|
0.839
|
0.107
|
|
Bloating
|
77 (61–94)
|
74 (50–88)
|
73 (59–95)
|
80 (39–95)
|
0.079
|
0.850
|
0.861
|
|
Nausea and vomiting
|
95 (87–98)
|
95 (84–97)
|
97 (93–99)
|
98 (92–99)
|
0.035
|
0.305
|
0.011
|
|
Psychological well-being
|
87 (69–96)
|
78 (52–93)
|
93 (79–98)
|
85 (74–96)
|
0.000
|
0.036
|
0.682
|
|
Intestinal symptoms’ influence on daily life
|
93 (77–98)
|
90 (77–96)
|
94 (70–98)
|
96 (75–98)
|
0.027
|
0.928
|
0.703
|
- A lower value of the Visual Analogue Scale for Irritable Bowel Syndrome (VAS-IBS) indicates worse symptoms. Values are given as median, interquartile range (IQR). Wilcoxon’s signed rank test or Mann-Whitney U-test were used. P < 0.05 was considered statistically significant.
